GP Strategies buys out IC Axon to deliver training to pharma customers
Category: #health  By Pankaj Singh  Date: 2018-05-05
  • share
  • Twitter
  • Facebook
  • LinkedIn

GP Strategies buys out IC Axon to deliver training to pharma customers

GP Strategies Corporation, the international performance improvement solutions provider, has scarcely declared that it has purchased IC Axon, a leader in developing science-oriented training for life science and pharmaceutical companies. The acquisition is expected to strengthen GP Strategies' capabilities to deliver digital learning and comprehensive sales training services to its global pharmaceutical customer base.

For the uninitiated, IC Axon was founded in 1995 with its headquarters in Montreal, Canada. The company engages in designing and deploying customized clinical and sales training solutions for clients across the globe. IC Axon comprises a large team of in-house experts that includes editors, medical writers and dedicated referencing systems managers. IC Axon focuses on blending learning solutions and leveraging digital innovations, while also holding credit for putting together an award-winning visual communications team.

Don Duquette, Executive Vice President, Workforce Excellence at GP Strategies reportedly said that the existing GP Strategies team will be highly complemented with the addition of learning and development expertise that IC Axon will bring to the team. GP Strategies will now be able to offer its pharmaceutical customers expanded competence that delivers the most successful digital learning approaches. Duquette added that with the acquisition, GP Strategies is well on its way to become one of the most experienced and credentialed pharmaceutical sales training companies across the globe.

Carole Gins, CEO of IC Axon also welcomed the opportunity to combine IC Axon’s offerings with GP Strategies as a means to create a truly global, full-service pharmaceutical sales training agency. She added that GP Strategies and IC Axon can be said to be closely aligned as strategic partners when it comes to delivering high-quality services to customers.

Earlier in 2018, GP Strategies had also entered into a reseller agreement with ManchesterCF to offer training programs specifically designed for international banking and financial intelligence units within financial services and public-sector industries



About Author

Pankaj Singh

Email: [email protected]etsizeforecasters.com   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...